weight loss surgery vs glp-1 Matched subanalysis found no benefit in percent total body for preoperative #GLP-1 RA use controls at 12 months after bariatric surgery, suggesting the effect of these agents may be GLP-1 Weight Loss & Loose

NitroVasc Boost is best suited for those who are looking to encourage their overall cardiovascular health through support of healthy nitric oxide levels and flow-mediated dilation, a measure of healthy endothelial function and blood flow

While Basaglar can be prescribed for both type 1 and type 2 diabetes in adults and also in children aged 6+, Ozempic, however, is only approved for type 2 diabetes & isnt an option for people with type 1 diabetes TL;DR Basaglar (insulin glargine) and Ozempic (semaglutide) treat type 2 diabetes through completely different mechanisms Basaglar is a long acting basal insulin injected daily that directly replaces insulin your body lacks while Ozempic is a GLP 1 receptor agonist injected weekly that enhances your bodys natural insulin production Key differences: Ozempic promotes weight loss (10-15%) while Basaglar often causes weight gain Ozempic reduces A1C by 1.4-1.8% vs Basaglars 0.8-1.5%

Aysha Akhtar is employed at the non-profit organization CCS Center for Contemporary Sciences

This process was clearly optimized for speed and volume, not necessarily patient safety